Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients

Author(s):
Benham, H.; Nel, H.J.; Law, S.C.; Mehdi, A.M.; Street, S.; Ramnoruth, N.; Pahau, H.; Lee, B.T.; Ng, J.; Brunck, M.E.G.; Hyde, C.; Trouw, L.A. (0000-0001-5186-2290); Dudek, N.L.; Purcell, A.W.; O'Sullivan, B.J.; Connolly, J.E.; Paul, S.K.; Cao, K.A. le; Thomas, R.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-06-03
Language
English
Is part of
Science Translational Medicine (2015), No. 290
hdl
1887/107705
doi
10.1126/scitranslmed.aaa9301